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Abstract
Numerous studies using cultured mammalian cells have shown that the three GGAs (Golgi-localized, gamma-ear containing,
ADP-ribosylation factor- binding proteins) function in the transport of cargo proteins between the trans- Golgi network and
endosomes. However, the in vivo role(s) of these adaptor proteins and their possible functional redundancy has not been
analyzed. In this study, the genes encoding GGAs1-3 were disrupted in mice by insertional mutagenesis. Loss of GGA1 or
GGA3 alone was well tolerated whereas the absence of GGA2 resulted in embryonic or neonatal lethality, depending on the
genetic background of the mice. Thus, GGA2 mediates a vital function that cannot be compensated for by GGA1and/or
GGA3. The combined loss of GGA1 and GGA3 also resulted in a high incidence of neonatal mortality but in this case the
expression level of GGA2 may be inadequate to compensate for the loss of the other two GGAs. We conclude that the three
mammalian GGAs are essential proteins that are not fully redundant.
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Introduction
The GGAs (Golgi-localized, gamma-ear containing, ADP-
ribosylation factor- binding proteins) are a family of monomeric
clathrin adaptor proteins that facilitate trafficking of cargo proteins
from the trans-Golgi network (TGN) to endosomes [1]. Mammals
contain three GGAs, termed GGA1, GGA2, and GGA3. These
proteins have identical domain organizations with an N-terminal
VHS (VPS-27, Hrs, and STAM) domain followed by a GAT
(GGA and Tom1) domain, a connecting hinge segment and a C-
terminal GAE domain that is homologous to the ear domain of c-
adaptin [2]. The VHS and GAT domains of the three mammalian
GGAs are highly conserved with 60–75% identity [3].
The GGAs are recruited from the cytosol onto the TGN via
binding of the GAT domain to ARFNGTP and PI4P [3–5]. The
VHS domain then binds acidic-cluster dileucine (AC-LL) sorting
motifs present in the cytoplasmic tails of cargo molecules and
facilitates the incorporation of these molecules into forming
clathrin-coated carriers which deliver them to endosomes [2].
Cargo molecules known to interact with the GGAs include the
cation-independent and cation-dependent mannose 6-phosphate
receptors, sortilin, sortilin-related receptor (SorLA/LR11), b-
secretase (BACE1), low-density lipoprotein receptor-related pro-
teins 3, 9 and 12, stabilin-1, consortin, and chloride channel 7 [6–
16]. In addition to functioning at the TGN, GGA3 has also been
implicated in the sorting of ubiquitinated cargo at the endosomes
[17,18].
A critical question is whether the three mammalian GGAs have
distinct roles or are functionally redundant, as is the case with the
two yeast GGAs [19,20]. Since none of the cargo proteins known
to interact with the mammalian GGAs have been found to bind
exclusively to one particular GGA, it has generally been assumed
that these GGAs are likely redundant. However, the GGAs do
exhibit some differences in their binding to AC-LL motifs of the
various cargo proteins [8,10,16,21,22]. In addition, human GGA1
and GGA3 but not GGA2 are phosphorylated in vivo and subject
to autoinhibition mediated by binding of internal AC-LL motifs
present in the hinge to the ligand binding site on the VHS domain
[23,24]. The GAT domains of human GGA1 and GGA3 but not
GGA2 bind ubiquitin and ubiquitinated proteins [25,26]. Finally,
GGA2 has a shorter half-life than GGA1 and GGA3 [27].
It is also of note that the amino acid differences between the
GGAs are highly conserved among species. Thus, mouse GGA1 is
more similar to human GGA1 (91.1% identity) than human
GGA1 is to human GGA2 (47.7% identity), etc, as determined by
the SIM Alignment Tool of the ExPASy Proteomics Server (Swiss
Institute of Bioinformatics). This is consistent with each GGA
having a function not fully shared with the other GGAs. However,
attempts to establish specific roles for the individual GGAs have
been inconclusive. There are a number of reports where one or
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RNAi and the impact on the trafficking of cargo molecules was
followed [28–32]. None of these studies established a distinct role
for any of the three GGAs. Further, since all of the knock-down
studies were performed with cells in tissue culture, the in vivo role of
the GGAs in mammals has yet to be evaluated.
We now report the consequence of disrupting the genes
encoding GGA1, GGA2 and GGA3 in mice using insertional
mutagenesis. The major finding is that loss of GGA2 is lethal
whereas loss of GGA1 or GGA3 alone is well-tolerated. This
establishes that GGA2 mediates a function that cannot be
compensated by GGA1 and GGA3.
Results
Generation of Gga1, Gga3 and Gga1/3 null mice
To elucidate the role of the GGAs in vivo, mice deficient in each
of the GGAs were generated via insertion of a gene-trap cassette
(Figure 1A; Figure 2A and C; Figure 3A). Mouse embryonic-stem
(ES) cell-line ID AN0619 containing a gene-trap cassette inserted
within intron-7 of the mouse Gga1 gene, and ES cell-line ID
RRC067 containing a gene-trap cassette inserted within intron-1
of the mouse Gga3 gene were used to obtain founder heterozygous
(het) mice in a C57BL/6J and 129/Ola mixed genetic background
(Figure 1A). Progeny of the het matings were analyzed by PCR
(Figure 1B), and revealed a genotype distribution of the expected
Mendelian ratios for Gga1 and Gga3 offspring (not shown). A two-
step mating scheme starting with Gga1 het/Gga3 null mice was
used to obtain the Gga1/Gga3 double null mice (Gga1/3 null),
which were born in accordance with the expected Mendelian
ratios (Figure 1D).
Immunoblot analysis was performed on mouse brain lysates to
confirm the effect of the gene targeting on protein expression. As
illustrated in Figure 1C, GGA1 was either undetectable or
occasionally showed trace amounts (less than 1% of wt) in the
Gga1 and Gga1/3 null brain lysates, which we attribute to a low-
level of read-through transcription and alternate splicing around
the gene-trap cassette. The GGA1-b-galactosidase (b-gal) fusion
protein made in the Gga1 and Gga1/3 null strains encodes the first
203 amino acids corresponding to exons-1 through 7 (Figure 1A).
We do not believe this fusion protein could function as a dominant
negative since it is lacking most of the GAT domain, which is
required for the inhibitory effect of the dominant negative
construct [4]. GGA3 was undetectable in the Gga3 and Gga1/3
null brain lysates (Figure 1C). The GGA3-b gal fusion protein
encodes the first thirteen amino acids of GGA3, which
corresponds to exon-1 (Figure 1A) and cannot contribute to any
inhibitory effect.
There was no evidence for either destabilization or upregulation
of the remaining GGAs, as noted in a previous tissue-culture based
study [28], and the level of adaptor protein 1 (AP-1) was similar
between the different genotypes. Although it has been reported
that depletion of any single GGA by RNAi causes a partial
reduction in the levels of the accessory protein p56 in HeLa cells
[31], we did not observe this effect in brain lysates isolated from
the Gga1, Gga3,o rGga1/3 null strains (Figure S2A). One possible
explanation for these discrepancies is that the Gga null mice have
adapted to the loss of individual GGAs differently than that
observed in the tissue-culture based systems.
Phenotypic characterization of Gga1, Gga3, and Gga1/3
null mice
The Gga1 and Gga3 het mice were comparable to their wild-type
(wt) counterparts at all ages. Mice homozygous null for Gga1 or
Gga3 alleles exhibited reduced birthweights (Figure 1E), but no
excess neonatal mortality (9% for Gga1 and Gga3 null mice vs 7%
for wt). They gained weight somewhat slower than their wt
littermates while their nose-rump lengths (NRL) were not different
(Figure 1F and G). Their lifespans and fertility were normal.
By contrast, the Gga1/3 null mice, while born at a normal ratio,
had a 47% (17/36) mortality rate within 24 hours post-partum
(Figure 1D). An additional 11% of these mice died within 3 weeks
(4/36). The Gga1 het/Gga3 null mice also exhibited increased
neonatal mortality (25/93) but this was half that observed with the
Gga1/3 null mice. The newborn Gga1/3 null mice had a reduced
birthweight similar to that of the Gga1 and Gga3 single null mice
(Figure 1E). The surviving Gga1/3 null mice gained weight even
more slowly than the single nulls, and at 20 weeks exhibited a 38%
reduction in weight compared to wt with no difference in NRL
(Figure 1F and G). The Gga1/3 null survivors had a normal
lifespan but exhibited extremely poor fertility, which precluded
generation of the Gga1/3 null line.
We have previously reported that mice deficient in the gene
(Gnptab) that encodes N-Acetylglucosamine-1-phosphotransferase,
the enzyme that generates the mannose 6-phosphate recognition
marker of lysosomal acid hydrolases, exhibit 6–40 fold elevations
in their plasma levels of these hydrolases [33]. In order to assess if
GGA deficiency also leads to similar enzyme hypersecretion in vivo,
assays for five different lysosomal acid hydrolases were performed
and the results are shown in Table 1. In contrast to the Gnptab null
mice, the Gga1, Gga3, and Gga1/3 null mice showed only a
marginal elevation (1.6 to 2.2 fold) of a subset of the acid
hydrolases. This indicates that lysosomal acid hydrolase sorting
remains mostly intact even when two of the three GGAs are
absent.
Generation of Gga2 null mice
ES cell-line ID SYA176 containing a gene trap cassette inserted
within intron-1 of the mouse Gga2 gene was used to generate
germline chimeras (Figure 2A). F1 het littermates in the C57BL/6J
and 129/Ola mixed genetic background were crossed with the
intent to generate Gga2 homozygous null mice. Of the 88 offspring
obtained on day 1 from the Gga2 het matings, 28 expressed only wt
message whereas 60 expressed both wt and chimeric message, as
determined by RT-PCR (Figure 2B and E; Figure S1A). In
addition, immunoblot analysis of brain lysates prepared from
several litters of these day-1 offsprings failed to reveal any Gga2
nulls (data not shown), in agreement with the RT-PCR data. The
absence of mutant mice expressing only chimeric mRNA or
lacking GGA2 protein indicated that inactivation of the Gga2 gene
causes embryonic lethality. To investigate the developmental stage
at which the Gga2 null fetuses die, embryos derived from timed
Gga2 het crosses were genotyped at different stages of gestation.
The pregnant mice were euthanized at embryonic-day (E)9, E10,
E11 and E12, followed by removal of the embryos and analysis of
tissue lysates for the presence or absence of GGA2 by Western
blotting. Of the 74 embryos analyzed, no Gga2 null embryos were
identified (Figure 2E). This indicates that the Gga2 null embryos
are dying before day E9 in this genetic background. An alternate
explanation for our RT-PCR and Western blot data was that read-
through transcription and splicing around the gene-trap cassette
was occurring even in homozygous null mice resulting in wt
mRNA and protein synthesis, as has been reported for a number
of other gene-trap constructs [34,35]. Since we were initially
unable to genotype these Gga2 mice at the genome level, the latter
possibility could not be ruled out at the time. We were also
concerned that perhaps this particular gene-trap cassette was
causing embryonic lethality by a mechanism independent of the
Gga Null Mice
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[36].
For these reasons, we generated a second Gga2 mutant strain
using a different ES cell line. ES cell-line IST10483E10 containing
a gene-trap cassette inserted within a known site in intron-1 of the
mouse Gga2 gene was used to generate germ-line chimeras in a
C57BL/6J background (Figure 3A). In this background, genotyp-
ing of 169 newborn pups (Figure 3B) demonstrated that the mice
were born in near accordance with the expected Mendelian ratio,
although the homozygous group was moderately underrepresent-
Figure 1. Analysis of Gga1, Gga3 and Gga1/3 null mice. A) The position of the gene-trap within intron-7 of the mouse Gga1 gene is shown along
with the position of the gene-trap within intron-1 of the mouse Gga3 gene. As a consequence of these gene-traps, normal mRNA is disrupted by the
splice acceptor site of the engrailed-2 leader sequence fusing with either codon-203 (encoding E203) of the mouse Gga1 gene or codon-14 (encoding
S14) of the mouse Gga3 gene. Gga1 and Gga3 PCR primer sets fwd1/rev1 and fwd1/rev2 (Figure S1A) were used to distinguish between wt and null
genotypes, respectively. B) PCR of genomic DNA was performed using Gga1 specific primers, (Gga1 PCR, reaction i) Gga3 specific primers (Gga3 PCR,
reaction i), and a Gga1 specific primer or Gga3 specific primer in combination with a gene trap specific primer (reactions ii). PCR band in reactions (i)
indicates wt genotype, while PCR band in reactions (ii) indicates null genotype. C) Western blot analysis of mouse brain lysates probed for GGA1,
GGA2, GGA3, AP-1 and GAPDH (loading control). * denotes a GGA1- cross reacting band (see Figure S4). D) Gga1
+/2/Gga3
2/26Gga1
+/2/Gga3
2/2
matings were set up and the resulting mice were genotyped by PCR as described in panels A and B. E) Birthweights were obtained on day 1 and
plotted according to genotype (wt, n=10; Gga1
2/2, n=23; Gga3
2/2, n=20; Gga1
2/2/3
2/2, n=20). * represents p=,0.001; as determined by
Student’s t-test. F and G) Weights and nose-rump lengths (NRL) of wt (blue), Gga1
2/2 (red), Gga3
2/2 (yellow) and Gga1
2/2/3
2/2 (green) mice were
obtained at the times indicated and plotted versus age in weeks. * represents p,0.05, ** represents p,0.001; as determined by Student’s t-test.
doi:10.1371/journal.pone.0030184.g001
Gga Null Mice
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30184Figure 2. Analysis of Gga2 null mice (SYA176 strain). A) Insertion of the gene-trap cassette within intron-1 of the mouse Gga2 (SYA176) gene
results in normal GGA2 mRNA being disrupted by the splice acceptor site of the engrailed-2 leader sequence fusing with codon-33 (encoding L33) of
the mouse Gga2 gene. The progeny of Gga2
+/2 inter-crosses were genotyped by subjecting cDNA to RT-PCR with Gga2 primer sets fwd1/rev1
(spanning exons-1 through 5) and fwd1/rev2 (spanning exon-1 and the b-galactosidase exon) (Figure S1A), which differentiated between the wt and
null genotypes, respectively. B) RT-PCR of cDNA prepared from white blood cells or brain tissue was performed using Gga2 specific primers (reactions
i) or a Gga2 specific primer in combination with a gene trap specific primer (reactions ii). PCR band in reactions (i) indicates wt genotype, while PCR
band in reactions (ii) indicates null genotype. C) Determination of the insertion site of the gene-trap within intron-1 of the mouse Gga2 gene (SYA176)
allowed for the design of Gga2 primer sets fwd1/rev1 and fwd1/rev2 (Figure S1A), which clearly distinguished between wt and null genotypes,
respectively, at the gene level. D) PCR of genomic DNA was performed using Gga2 specific primers (reactions i) or a Gga2 specific primer in
combination with a gene trap specific primer (reactions ii). PCR band in reactions (i) indicates wt genotype, while PCR band in reactions (ii) indicates
null genotype. E) The genotypes of the Gga2
+/2 crosses were determined either by RT-PCR (day1 pups) or Western blots (embryos E9, E10, E11 and
E12). No homozygous null were obtained out of 162 newborns or embryos that were analyzed. F) PCR was performed using genomic DNA from
newborn pups of SYA176 Gga2
+/2 crosses in the C57BL/6J background. No homozygous nulls were obtained out of 45 pups analyzed.
doi:10.1371/journal.pone.0030184.g002
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e30184Figure 3. Analysis of Gga2 null mice (TIGM strain). A) The position of the gene-trap within intron-1 of the mouse Gga2 gene (cell line,
IST10483E10) is shown. As a consequence of this gene-trap, normal messenger RNA (mRNA) is disrupted by the splice acceptor site of the engrailed-2
leader sequence fusing with codon-33 (encoding L33) of the mouse Gga2 gene. Gga2 primer sets fwd1/rev1 and fwd1a/rev2 (Figure S1A) were used
to clearly distinguish between wt and null genotypes, respectively. B) PCR of genomic DNA was performed using Gga2 specific primers (reactions i) or
a Gga2 specific primer in combination with a gene trap specific primer (reactions ii). PCR band in reactions (i) indicates wt genotype, while PCR band
in reactions (ii) indicates null genotype. C) PCR was performed using genomic DNA from newborn pups of TIGM Gga2
+/2 crosses. 169 pups were
analyzed and homozygous insertion of the gene-trap into the Gga2 gene was determined to be 95% lethal by 3 weeks of age. D) Western blot
analysis of TIGM Gga2 mouse brain lysates probed for GGA1, GGA2, GGA3, AP-1 and GAPDH. * denotes a GGA1- cross reacting band (see Figure S4).
doi:10.1371/journal.pone.0030184.g003
Table 1. Lysosomal enzyme activities in plasma of Gga null mice.
wt Gga1 null Gga3 null Gga1/3 null
Enzyme Avg ± SD Avg ± SD Fold q Avg ± SD Fold q Avg ± SD Fold q
a-mannosidase 7006275 11386315* 1.63 8226257 1.17 11656377* 1.66
b-mannosidase 138641 246693* 1.78 227679* 1.64 306639* 2.22
a-galactosidase 26614 2868 1.08 2569 0.96 4869 1.85
b-galactosidase 15652 6 611* 1.73 1667 1.07 1867 1.2
b-glucuronidase 22682 3 66 1.05 1964 0.86 1864 0.82
Enzyme activity is expressed as nmole product formed/h/ml.
Fold q=null activity/wt activity.
n=28 for all mice except the Gga1/3 null where n=10.
*=p value,0.001.
doi:10.1371/journal.pone.0030184.t001
Gga Null Mice
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were cannibalized before they could be genotyped. To evaluate
this possibility, an additional 99 newborns were genotyped within
12 hours of delivery to avoid loss of pups by cannibalism. In this
set, the Gga2 null mice represented 26% of the total (versus 29% wt
and 45% het), confirming that the Gga2 null mice in the C57BL/
6NJ background were being born in the expected Mendelian ratio.
Immunoblot analysis of brain lysates established the absence of
GGA2 in the Gga2 null newborn mice (Figure 3D), while the levels
of the other GGAs, AP-1 and p56 were unchanged (Figure 3D;
Figure S2B).
Strikingly, 73% of the mice that were homozygous for the gene-
trap insertion died within the first 48 hours of birth and all of the
remaining mice (with one exception) died within the first three
weeks (Figure 3C). Dermal fibroblasts derived from the single
survivor confirmed the null status of this mouse (Figure S3A).
Thus, loss of GGA2 is lethal in both genetic backgrounds although
it occurs during embryogenesis in one instance and during the
early neonatal period in the other.
In order to evaluate the contribution of genetic background to
the embryonic lethality of the SYA176 strain, Gga2 het mice in the
mixed background were backcrossed for 8 generations with wt
C57BL/6J mice. Breeder pairs were set up with the eighth
generation het mice and 45 offspring from these matings were
sacrificed on day 1 and analyzed by a combination of genomic
PCR and Western blotting (Figure 2F). Thus, determination of the
insertion site of the gene-trap cassette within the SYA176 strain,
accomplished while the backcrossing was being performed,
allowed for accurate discrimination between wt, het and null
genotypes in the backcrosses (Figure 2C and D). No genetic nulls
were obtained by PCR (Figure 2D and F), or phenotypic nulls by
immunoblot analysis (not shown), indicating that this Gga2 strain
remains embryonic lethal despite being backcrossed into the
C57BL/6J background. One possible explanation for the
discrepancy is that the TIGM Gga2 mice are in the C57BL/6NJ
background, which is not genetically identical to the C57BL/6J
substrain (our SYA176 backcrossed mice), as described in the
Jackson Laboratory Resource Manual [37]. In this regard, we
have found no differences in brain expression of the three GGAs
between C57BL/6J mice and C57BL/6J-129/Ola mixed genetic
background mice (data not shown), suggesting that the strain or
substrain differences we observe are not due to differential
expression of the GGAs.
Since our Gga1 null mice are also of mixed parentage, it was
important to ascertain if genetic background could influence the
phenotype of this strain. Gga1 het mice that were backcrossed for
eight generations into the C57BL/6J strain were intercrossed, and
the results indicate that Gga1 nulls in the black background are
born in accordance with Mendelian ratio and are phenotypically
normal (data not shown), demonstrating that the observed lethal
phenotypes are unique to Gga2. A similar backcross into the
C57BL/6J background is presently underway for the Gga3 nulls.
Phenotypic characterization of Gga2 null mice
Although 95% of the Gga2 null mice derived from the TIGM
cell line IST10483E10 died within 3 weeks of birth, histological
examination revealed no obvious abnormalities. These Gga2 null
mice were significantly smaller than their littermates at birth
(Figure 4A), but they were able to feed as evidenced by the
presence of milk in their stomachs. Nevertheless, the null mice
displayed striking hypoglycemia. Blood glucose levels obtained on
postnatal day 1 averaged 28610 mg/dL (n=12) whereas the
values of the wt and het mice were 41612 mg/dL (n=42) and
44614 mg/dL (n=54), respectively (Figure 4B). Interestingly, the
Gga1, Gga3 and Gga1/3 null mice also exhibited hypoglycemia on
postnatal day 1 (Figure 4C).
Expression of GGAs
One possible explanation for the embryonic/neonatal lethality
associated with the Gga2 null mice is that GGA2 is selectively
expressed during embryogenesis and the neonatal period,
resulting in the total loss of GGAs at these stages of development.
Alternatively, GGA2 could be expressed at much higher levels
than GGA1 and GGA3 during embryogenesis such that in its
absence, the residual content of GGAs is insufficient to mediate
some critical function. To address these possibilities, we
developed a quantitative Western blot procedure to determine
the level of each GGA during embryonic development and at
adulthood. Brain extracts were prepared from wt embryos of
mixed genetic background at various time points and analyzed by
Western blotting to determine the content of the three GGAs at
these stages, using purified GGAs 1–3 as standards. All three
GGAs were detected at all stages of development (Figure 5A).
GGA2 expression was highest at embryonic day 9 through the
end of week 1, and then declined quite substantially achieving the
lowest level in the adult brain (Figure 5A and C). By contrast,
GGA1 and GGA3 expression increased from day E9 through day
E18 and brain levels remained consistently high through adult
stage. Importantly, when the expression level of the three GGAs
was quantitated using the standards on each blot, it was apparent
that the level of GGA2 was somewhat lower than the levels of
GGA1 and GGA3 during the various stages of embryonic
development (Figure 5A). Also, GGA2 was expressed at a much
lower level than the other two GGAs in the adult rodent brain. A
striking similarity was noted with adult human brain in that
GGA2 was virtually undetectable whereas good expression was
noted for GGA1 and GGA3 (Figure S3B). All three GGAs, on the
other hand, were readily detected in human embryonic kidney
293 cells and Hela cells (Figure S3B). Mouse fibroblasts, in
contrast, lack detectable GGA3, but express GGA1 and GGA2
(Figure S3A). Similarly, testis obtained from 2-week old wt mice
had only trace amounts of GGA3 whereas the level of GGA1 was
comparable to that found in the brain and GGA2 expression was
higher than in the brain (data not shown). These results show that
GGA expression can vary dramatically between tissues in both
humans and mice. Also, the data are in agreement with
microarray data showing that GGA2 mRNA expression is much
higher in mouse embryos relative to adult brain (Mouse Gene
Sorter, UCSC Genome Bioinformatics, http://genome.ucsc.edu/
). Thus, at least in the brain, the level of GGA1 and GGA3
expression during embryogenesis would appear to be sufficient to
compensate for the loss of GGA2 if the three GGAs were
functionally redundant.
We also performed conventional real-time RT-PCR on total
RNA prepared from wt adult tissues to determine the message
levels of the three GGAs in brain, liver, kidney, heart, fat and lung.
This analysis revealed that the GGA1 mRNA is most highly
expressed in the kidney, brain and fat whereas GGA3 mRNA is
expressed highest in brain followed by fat while GGA2 mRNA is
most highly expressed in fat and the kidney (Figure 5B).
To further characterize the tissue specific expression of the
GGAs in adult tissues, an immunoblot analysis was performed on
tissues from wt mice. Consistent with the real-time RT PCR,
GGA1 was most highly expressed in brain and fat whereas GGA3
had the highest expression in the brain and GGA2 in the fat
(Figure 5D). The values obtained with the kidney extracts were
quite variable which we attribute to protease activity, resulting in
rapid degradation of the GGAs.
Gga Null Mice
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These data demonstrate that the GGAs are essential proteins in
mammalian cells. They also provide two key findings concerning
the issue of redundancy. First, while the individual loss of either
GGA1 or GGA3 in mice is well-tolerated, the absence of GGA2
causes either embryonic or neonatal lethality, depending on the
genetic background of the strain. And second, the combined loss of
GGA1 and GGA3 results in a high incidence of mortality during
the first day of life. The requirement for GGA2 indicates that this
adaptor protein carries out a vital function that cannot be
compensated for by GGA1 and GGA3. However, the nature of
this critical function(s) is not clear at this time.
It is of interest that the expression level of GGA2 in the rodent
brain is highest during embryonic development and early life but
decreases substantially two weeks after birth. This is consistent
with GGA2 serving a very important function during the
embryonic and neonatal stage. This finding, however, does not
obviate a role for GGA2 in adult animals since GGA2 is highly
expressed in adipose tissue and fibroblasts (Figure 5B and D;
Figure S3A). In contrast, brain expression of GGA1 and GGA3
remains consistently high from late embryogenesis through
adulthood. The fact that the levels of GGA1 and GGA3 are
somewhat greater in the brain than the level of GGA2 during
development excludes the possibility that GGA2 is the sole GGA
present in this organ. However, the GGA levels in the other tissues
Figure 4. Gga2 null mice exhibit low birthweights and hypoglycemia. A) Birthweights were obtained on day 1 and plotted according to
genotype (wt, n=42; Gga2
+/2, n=54, Gga2
2/2, n=12). * represents p,0.001; as determined by Student’s t-test. B) Blood glucose levels in TIGM Gga2
newborn mice were determined on day 1 and plotted according to genotype (wt, n=42; Gga2
+/2, n=54, Gga2
2/2, n=12) * represents p,0.001; as
determined by Student’s t-test. C) Blood glucose levels in Gga1 and Gga3 newborn mice were determined on day 1 and plotted according to genotype
(wt, n=10; Gga1
2/2,n=2 3 ;Gga3
2/2,n=2 0 ;Gga1
2/2/3
2/2, n=20). * represents p,0.001, ** represents p,0.05; as determined by Student’s t-test.
doi:10.1371/journal.pone.0030184.g004
Gga Null Mice
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background, the Gga2 null newborn mice are small, but
histological examination of their organs on day 1 did not reveal
any obvious abnormalities. These mice did have quite low blood
glucose levels even though they had detectable milk in their
stomachs indicating that they are able to suckle and take in milk.
At this point the etiology of the low blood glucose is unknown and
its possible contribution to the early demise of these mice is not
clear.
Interestingly, the one female Gga2 null mouse that survived is
now an adult and has no obvious abnormalities to date other
than being 25% smaller than its littermates. This indicates that
GGA2 may be dispensable after the neonatal period and is
consistent with the low expression level seen in rodent and
human adult brains. This female mouse has been crossed with a
Gga2 het male and produced two small litters (5 and 3 pups, all
of which died). The finding that the Gga2 null mice in the mixed
C57BL/6J and 129/Ola background (SYA176 strain) die before
embryonic day 9 suggested that genetic background may
influence the tolerance to the loss of GGA2. However, when
t h eS Y A 1 7 6m i c ew e r eb a c k c r o s s e di n t ot h eC 5 7 B L / 6 J
background, the embryonic lethal phenotype remained, as
Figure 5. Tissue expression of GGA proteins. A) 25 mg of E9 whole embryo and E14, E18 and adult brain lysates along with 2–8 ng of purified
standards were subjected to SDS-PAGE and immunoblot analysis. GGA1 and GGA2 purified standards were full-length Flag-tagged mouse proteins
while the GGA3 standard was the mouse protein encoding only the VHS-GAT domain (see Figure S4A). Blots were probed for GGA1, GGA2, GGA3, AP-
1 and GAPDH. Quantitation was derived from comparison to the GGA standards. # denotes a longer exposure of the GGA2 Western blot. B) The
mRNA levels in mouse tissues were determined by quantitative realtime PCR and expressed relative to the expression of b-actin. First strand cDNA
was synthesized from total RNA by reverse transcription as described in Materials & Methods. Realtime PCR was performed with SYBR Green Kit (ABI).
The values presented are the average of two independent runs with total RNA isolated from the indicated organs of a wt mouse of C57BL/6J-129/Ola
mixed genetic background. C) 25 mg of wt mouse brain lysates from mice (day 1 through adult stage) were subjected to SDS-PAGE and immunoblot
analysis. Blots were probed as in panel A. D) 25 mg of wt adult mouse lysates (brain, liver, heart, lung and fat) were subjected to SDS-PAGE and
immunoblot analysis. Blots were probed as in panel A.
doi:10.1371/journal.pone.0030184.g005
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closer look at the genetics of the two strains revealed that they
are not identical as the SYA176 strain is in the C57BL/6J
background while the TIGM strain is in the C57BL/6NJ
background. It is thought that the many phenotypic differences
among such closely related substrains could be due to as yet
undiscovered genetic modifiers [37]. Furthermore, changes in
gene expression clustered up to 28 MB of several knockout loci
have been reported despite eleven generations of backcrosses
into the C57BL/6 background, likely due to polymorphisms
originating from the parental ES cells that alter gene expression
[38]. Another remote possibility is that some important
nucleotide element, such as a micro RNA, is situated in the
2 kb segment of intronic sequence between the upstream gene-
trap insertion site in the SYA176 strain and the downstream
insertion site in the TIGM strain, such that this critical element
is only lacking in the chimeric GGA2 pre-mRNA in the SYA176
strain, and therefore contributes to its embryonic lethality [36].
The finding that loss of either GGA1 or GGA3 is well tolerated
whereas the combined loss of both these GGAs results in a high
incidence of neonatal lethality raises the possibility that these two
GGAs share at least one vital function that cannot be carried out
by GGA2. In this regard, both GGA1 and GGA3 are more
similar to one another than to GGA2 in that both are highly
phosphorylated, subject to autoinhibition and bind ubiquitin
whereas GGA2 exhibits none of these properties [17,23–25].
Moreover, crystallographic studies suggest that GGA1 and
GGA3 VHS domains are more similar to each other than to
the GGA2 VHS domain [39]. An alternative possibility for the
partially lethal phenotype associated with the combined loss of
GGA1 and GGA3 is that the expression level of GGA2 in some
critical organ/tissue is not sufficient to overcome the loss of the
other GGAs. It is of note that the Gga1/3 null mice that lived
beyond one month had a normal lifespan although their weight
remained significantly lower than that of wt mice. Thus, as in the
case of GGA2, GGA1 and GGA3 may not be required for
survival after the neonatal-period.
While this manuscript was in preparation, two independent
studies were published in which the single GGA gene in Drosophila
melanogaster was knocked-down using GGA transgenic RNAi fly
lines [40,41]. Although the study by Hirst and Carmichael did not
show any obvious phenotype when greater than 95% of the GGA
is depleted in flies, the authors did note a gender specific higher
expression of GGA in male flies [40]. In contrast, Eissenberg et al
reported that GGA depletion resulted in lethality during early
pupation under certain circumstances [41]. The basis for this
discrepancy is not clear at this point.
The mammalian GGAs have been implicated in the trafficking
of a number of transmembrane proteins including the mannose 6-
phosphate receptors, sortilin, SorLA and BACE1 in in vitro studies.
The knock-out mice described herein should be useful in
determining the physiological roles of GGA1 and GGA3 in the
intracellular pathways mediated by these receptors.
Materials and Methods
All protocols involving the use of animals were in compliance
with the National Institutes of Health’s Guide for the Care and
Use of Laboratory Animals and approved by the Animal Studies
Committee in the Division of Comparative Medicine at Wash-
ington University School of Medicine in St. Louis (Protocol #
20100074). Mice were housed in a barrier facility maintained
under standards meeting federal, state and local guidelines and
under the supervision of licensed veterinarians.
Generation of Gga null mice
The Gga1 null mouse was generated from an ES clonal cell-line
(cell-line ID AN0619) of 129P2/OlaHsd origin that was provided
by the Sanger Institute (Cambridge, United Kingdom). This ES
cell-line has a gene-trap cassette inserted within intron-7 of the
mouse Gga1 gene. The cell-line was expanded and injected into
blastocysts derived from C57-BL/6J mice at the ES/Mouse
Genetics Core facility of Washington University School of
Medicine in St. Louis. Several male mice displaying at least
50% chimerism were bred with female C57-BL/6J mice for germ-
line transmission. Founder Gga1 het mice were initially identified
by performing PCR across a segment of the neomycin gene within
the gene-trap cassette. Since the precise location of the gene-trap
within the 2.2 kb intron-7 of the Gga1 gene was unknown,
genomic DNA isolated from Gga1 het mice was used to first
accurately map this site by a combination of genomic PCR and
DNA sequencing techniques (not shown). Upon acquiring this
information, three primers were designed close to the insertion
site, tested and verified, and subsequently used to genotype the
progeny of inter-crosses between the Gga1 het mice (Figure 1A and
B; Figure S1A). Since these Gga1 mice are in the C57BL/6J and
129/Ola mixed genetic background, they were backcrossed for
eight generations with C57BL/6J wt mice to obtain an incipient
congenic line.
Generation of the Gga3 null mouse was initiated at the Mutant
Mouse Regional Resource Center (MMRRC) in San Diego from
an ES clonal cell-line (cell-line ID RRC067) of 129P2/OlaHsd
origin that had a gene trap inserted in intron-1 of the mouse Gga3
gene. Male chimeric mice were shipped to our institute for
breeding with female C57-BL/6J mice. Founder Gga3 het mice
were initially screened by PCR across a segment of the neomycin
gene. The insertion site of the gene trap within the 8.9 kb intron-1
of the Gga3 gene was mapped precisely using genomic DNA
isolated from a Gga3 het mouse (not shown). PCR primers were
then designed as before and used to genotype the progeny of a
Gga3 het inter-cross (Figure 1A and B; Figure S1A).
An ES clonal cell-line (cell-line ID SYA176) of 129P2/OlaHsd
origin from the MMRRC that had a gene trap inserted in intron-1
of the mouse Gga2 gene was utilized to generate the Gga2 het mice.
Male chimeric mice were bred with female C57-BL/6J mice and
Gga2 founder pups were screened by PCR across a segment of the
neomycin gene. We were initially unable to precisely map the
insertion site of the gene trap cassette within the 8.8 kb intron-1 of
the Gga2 gene within this strain; consequently, we designed PCR
primer sets that span exons-1 through 5, or exon-1 and the b-gal
exon, and used these to genotype the progeny of Gga2 het inter-
crosses using cDNA prepared by RT-PCR from either white blood
cells or brain tissue (Figure 2A and B; Figure S1A). To verify the
specificity of the PCR amplification generated with each primer
set, PCR products were gel-isolated and sequenced (Figure S1B).
When the position of the gene-trap cassette was eventually
determined, PCR primers were designed to span the insertion
site allowing us to clearly distinguish between Gga2 wt, het and null
mice (Figure 2C and D; Figure S1A). Since these Gga2 het mice,
like the Gga1 strain, are also of C57BL/6J and 129/Ola mixed
genetic background, they were backcrossed for eight generations
with C57BL/6J wt mice to obtain an incipient congenic line.
A second ES clonal cell-line (cell-line ID IST10483E10) of
C57BL/6N origin from Texas A&M Institute for Genomic
Medicine (TIGM, College Station, TX) that had a gene trap
inserted in intron-1 of the mouse Gga2 gene was utilized to
generate the Gga2 (TIGM) het mice. Male chimeric mice in the
black background were bred with female C57-BL/6J mice and
Gga2 founder pups were screened by PCR across a segment of the
Gga Null Mice
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gene-trap cassette within intron-1 of the Gga2 gene in this strain
was available from TIGM, which facilitated the design of primers
to enable genotyping of the progeny of a Gga2 het inter-cross
(Figure 3A and B; Figure S1A). The sizes of all PCR and RT-PCR
fragments associated with the various Gga null mice in this study
are presented in Figure S2A.
PCR conditions for genotyping of mice
For genotyping of mice, genomic DNA was prepared from toe/
tail tissue by boiling in 300 ml of alkali (1:200 diluted solution of
10N NaOH) for 1 hr, followed by neutralization with 25 mlo f1M
Tris.Cl, pH 8.0. 1 ml of this crude DNA extract was used for PCR
analysis using the various primer sets shown in Figure S1A. PCR
cycling conditions were as follows: step 1–95uC 2.5 min; step 2–
95uC 50 sec; step 3–62uC 50 sec; step 4–72uC 1 min; step 5 -
repeat cycles two through four 32 times; step 6–72uC 10 min. All
PCR products were analyzed on 2% agarose gels. The fragment
sizes of the PCR products generated with the different primer sets
are shown in the supplementary data.
Harvesting mouse tissues and Western blot analyses
Adult mice were euthanized by CO2 inhalation while newborns
and embryos were sacrificed by decapitation. For the embryo
analysis, day E9 whole embryo, E12 and E14 whole head and E18
brain tissue were used. Adult brain, kidney, liver, heart, white fat
and lungs were removed and weighed. 100 mg of each tissue
sample was rinsed in phosphate-buffered saline (PBS) and five
volumes of PBS with 1% Triton X-100 (PBS-T) containing
proteinase inhibitors (Roche) were added. Tissues were homoge-
nized in 1.7 ml microcentrifuge tubes on ice using a Teflon pestle.
Homogenates were centrifuged at 15,0006g for 15 min and the
supernatants were removed, and the protein concentrations
determined. All samples were diluted to 5 mg/ml before being
boiled in SDS sample buffer for gel loading. Proteins were resolved
by SDS-PAGE, transferred to nitrocellulose membrane and
probed with the following antibodies: anti-GGA1 (GGA1 H-215
for both mouse and human proteins) (Santa Cruz), anti-GGA2
(GGA2 H-175 for mouse protein) (Santa Cruz), anti-GGA2 (cat
#612613 for human protein) (BD Transduction Laboratories),
anti-GGA3 (made against purified VHS-GAT domain of
recombinant mouse GGA3 to detect mouse protein; see Figure
S3A and B), anti-GGA3 (cat#612311 for human protein) (BD
Transduction Laboratories), anti-AP-1 (cat#610385 for mouse
and human proteins) (BD Transduction Laboratories), anti-p56
(custom synthesized for us by Covance; see Supplementary data),
b-tubulin (Sigma) and GAPDH (Sigma).
Analyses of GGA mRNA in mouse tissues
Tissues were homogenized in TRIzol reagent (Invitrogen) and
total RNA was extracted according to the manufacturer’s
instructions. Superscript First Strand Synthesis system (Invitrogen)
was used to synthesize cDNA. The expression of mRNA was
examined by quantitative PCR analysis using a 7500 Fast Real-
Time PCR machine (Applied Biosystems). Amplimers for GGA1,
GGA2 and GGA3 (ABI; catalog # PPM35135A, PPM27582A,
PPM30931A, respectively) were employed using SYBR Green
detection. The relative mRNA expression was normalized by
measurement of the amount of b-actin mRNA in each sample. b-
actin primer 59- GACCCTGAAGTACCCCATTGAAC AND
59-CACGCAGCTCATTGTAGAAGGT. The PCR cycling con-
ditions were as follows: step 1–95uC 5 min; step 2–94uC 30 sec;
step 3–60uC 30 sec; step 4–72uC 20 sec; step 5–78uC 1 sec for
plate reading; step 6 – repeat cycles two through five 40 times; step
6–72uC 10 min.
Lysosomal enzyme assays
Lysosomal hydrolase activities were measured by fluorometric
analysis as described previously [33]. Briefly, various 4-methy-
lumbelliferyl-coupled substrates (5 mM) were incubated with
plasma samples isolated from the indicated mice in a 50 mM
citrate buffer containing 0.5% TritonX-100, pH 4.5, at 37uC.
Reactions were terminated by addition of 0.1 M glycine-NaOH
solution, pH 10.3, and the resulting fluorescence was read at
495 nm. Activities are expressed as nanomoles of methylumbelli-
ferone released per hour per milliliter of plasma.
Glucose levels
Glucose levels were determined with the One Touch Glucose
monitoring kit (Johnson & Johnson) using 10 mL of blood isolated
from tails of newborn (day 1) mice. Blood glucose levels are
represented as individual points with an average 6 standard
deviation.
Histology
Paraformaldehyde-fixed newborn mice or tissues isolated from
three week- old mice were cut in 5 mm sections. Sections were
applied to slides and stained with Hematoxylin–eosin.
Expression and purification of mouse GGAs
Full-length mouse GGA1 and GGA2 and the VHS/GAT
domains of mouse GGA3 with a Flag epitope were expressed in
SF9 insect cells and purified to homogeneity on anti-Flag M2
affinity gel according to the manufacturers protocol (Sigma).
Protein concentrations were determined by the Bradford assay
(BioRad) and the purified proteins were used as standards in the
immunoblot analysis.
Supporting Information
Figure S1 Gga and gene-trap primers used to genotype
mice. A. The Gga1, Gga3, Gga1/3, Gga2 (SYA176) and Gga2
(TIGM-IST10483E10) genotypes were assessed by PCR analysis
of genomic DNA as described under Materials and Methods.
Additionally, Gga2 (SYA176) was typed by RT-PCR of cDNA
prepared from blood or brain tissue. Two sets of primers detected
the wt or Gga1
2/2 allele. Gga1 primers fwd1 and rev1 yielded a
444-bp product specific for the wt allele, and primers fwd1 and
rev2 yielded a 520-bp fragment specific for the Gga1 allele
containing the gene-trap. Two sets of primers detected the wt or
Gga2
2/2 allele. For the SYA176 strain, Gga2 primers fwd1 and
rev1 yielded a 348-bp product specific for the wt allele, while
primers fwd1 and rev2 yielded a 592-bp fragment specific for the
Gga2 allele containing the gene-trap. For the TIGM strain, Gga2
primers fwd1 and rev1 yielded a 615-bp product specific for the wt
allele, while primers fwd1a and rev2 yielded a 326-bp fragment
specific for the Gga2 allele containing the gene-trap. Two sets of
primers detected the wt or Gga3
2/2 allele. Gga3 primers fwd1 and
rev1 yielded a 494-bp product specific for the wt allele, and
primers fwd1 and rev2 yielded a 465-bp fragment specific for the
Gga3 allele containing the gene-trap. For RT-PCR, two sets of
primers detected the wt or chimeric mRNA. Gga2 primers fwd1
and rev1 yielded a 464-bp product specific for the message
transcribed from the wt allele, while primers fwd1 and rev2 yielded
a 555-bp fragment specific for the message transcribed from the
Gga2 allele containing the gene-trap. B. To verify the specificity of
the PCR amplification products generated from the cDNA of the
Gga Null Mice
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B1 corresponds to wt Gga2 mRNA, while B2 corresponds to Gga2
exon-1 spliced to the b-gal exon.
(EPS)
Figure S2 Analysis of p56 in Gga null mice. A. Analysis of
p56 in Gga1, Gga3 and Gga1/3 brains of adult mice. 25 mg of total
protein from whole brain lysates was resolved by SDS-PAGE,
transferred to nitrocellulose and probed with anti-p56 rabbit
polyclonal antibody made against the synthetic peptide described
by Mardones et al. [31] and custom-synthesized for us by
Covance. GAPDH was detected with an anti-GAPDH mouse
monoclonal antibody. B. Analysis of p56 in Gga2 (TIGM) brains of
day 1 pups. Samples were prepared and analyzed as in A.
(EPS)
Figure S3 Low expression of GGA2 in mouse and
human adult brain. A. Comparison of GGA2 expression
between mouse adult brain and primary dermal fibroblasts shows
greatly diminished level in brain. In contrast, GGA1 is expressed
well in both tissues while GGA3 shows high expression in brain
but extremely low level in fibroblasts. The absence of the GGA2
signal in fibroblasts derived from the single surviving Gga2 null
mouse demonstrates the specificity of the signal. B. Similar to
mouse, the level of GGA2 expression is below the detection limit
in human adult brain. However, it is also quite low in fibroblasts,
but readily detected in HEK 293 and Hela cells. In contrast,
GGA1 and GGA3 are expressed at good levels in all four tissues/
cell-types examined.
(EPS)
Figure S4 Production and testing of mouse-specific
GGA3 pAb. A. Since none of the commercial anti-GGA3
antibodies specifically detected mouse GGA3 in western blot
applications, mouse GGA3 (residues 1–345) was expressed in Sf9
insect cells, purified to homogeneity and used to immunize either
Gga3
2/2 or wt (control) mice for antibody production. This
strategy elicited an antibody response in some of the Gga3
2/2 mice
but none of the control animals. Western blot analysis of mouse
brain lysates using the mouse polyclonal anti-sera showed that
GGA3 expression was reduced in the Gga3
+/2 strain and ablated
in the Gga3
2/2. There was also an additional band that migrated
slightly above the 75 Kd marker that proved to represent cross-
reactivity with GGA1, as shown in panel B. B. The lower band
proved to be a GGA1 cross-reacting band, since it was absent in
Gga1
2/2 and reduced in Gga1
+/2 brain extracts.
(EPS)
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